BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mccrary JM, Goldstein D, Sandler CX, Barry BK, Marthick M, Timmins HC, Li T, Horvath L, Grimison P, Park SB. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy. Support Care Cancer 2019;27:3849-57. [DOI: 10.1007/s00520-019-04680-w] [Cited by in Crossref: 45] [Cited by in F6Publishing: 31] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Mizrahi D, Goldstein D, Trinh T, Li T, Timmins HC, Harrison M, Marx GM, Hovey EJ, Lewis CR, Friedlander M, Park SB. Physical activity behaviors in cancer survivors treated with neurotoxic chemotherapy. Asia Pac J Clin Oncol 2023;19:243-9. [PMID: 35879821 DOI: 10.1111/ajco.13834] [Reference Citation Analysis]
2 Osumi M, Sumitani M, Otake Y, Nishi Y, Nobusako S, Morioka S. Influence of vibrotactile random noise on the smoothness of the grasp movement in patients with chemotherapy-induced peripheral neuropathy. Exp Brain Res 2023;241:407-15. [PMID: 36565342 DOI: 10.1007/s00221-022-06532-2] [Reference Citation Analysis]
3 Tay N, Laakso E, Schweitzer D, Endersby R, Vetter I, Starobova H. Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients. Front Mol Biosci 2022;9:1015746. [DOI: 10.3389/fmolb.2022.1015746] [Reference Citation Analysis]
4 Wagoner CW, Capozzi LC, Culos-reed SN. Tailoring the Evidence for Exercise Oncology within Breast Cancer Care. Current Oncology 2022;29:4827-4841. [DOI: 10.3390/curroncol29070383] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Diotti D, Puce L, Mori L, Trompetto C, Saretti E, Contenti C, Marinelli L. The role of physical activity against chemotherapy-induced peripheral neuropathy: a narrative review. Explor Neuroprot Ther 2022. [DOI: 10.37349/ent.2022.00020] [Reference Citation Analysis]
6 Okumura M, Inoue J, Matsuda N, Sakai Y. Early Postoperative Rehabilitation for a Postpartum Woman with Motor Paralysis due to Spinal Cord Tumor Who Could Raise a Newborn Child after Emergent Delivery and Tumor Removal:A Case Report. Jpn J Rehabil Med 2022;59:421-426. [DOI: 10.2490/jjrmc.21028] [Reference Citation Analysis]
7 Wu C, Chan Y, Yen L, Chen Y, Lo C, Tseng L, Wang Y. Extremity Exercise Program in Breast Cancer Survivors Suffering from Chemotherapy-Induced Peripheral Neuropathy: A Feasibility Pilot Study. Healthcare 2022;10:688. [DOI: 10.3390/healthcare10040688] [Reference Citation Analysis]
8 Mezzanotte JN, Grimm M, Shinde NV, Nolan T, Worthen-Chaudhari L, Williams NO, Lustberg MB. Updates in the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Curr Treat Options Oncol 2022. [PMID: 35167004 DOI: 10.1007/s11864-021-00926-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
9 Jones KF, Wechsler S, Zulewski D, Wood L. Pharmacological and Nonpharmacological Management of Chemotherapy-Induced Peripheral Neuropathy: A Scoping Review of Randomized Controlled Trials. J Palliat Med 2022. [PMID: 35128938 DOI: 10.1089/jpm.2021.0512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jones KF, Merlin JS. Approaches to opioid prescribing in cancer survivors: Lessons learned from the general literature. Cancer 2022;128:449-55. [PMID: 34633657 DOI: 10.1002/cncr.33961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Brett Whalen L, Zachary Wright W, Kundur P, Angadi S, Modesitt SC. Beneficial effects of exercise on chemotherapy-induced peripheral neuropathy and sleep disturbance: A review of literature and proposed mechanisms. Gynecologic Oncology Reports 2022;39:100927. [DOI: 10.1016/j.gore.2022.100927] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Park SB, Tamburin S, Schenone A, Kleckner IR, Velasco R, Alberti P, Kanzawa-Lee G, Lustberg M, Dorsey SG, Mantovani E, Hamedani M, Argyriou AA, Cavaletti G, Hoke A; Toxic Neuropathy Consortium. Optimal outcome measures for assessing exercise and rehabilitation approaches in chemotherapy-induced peripheral-neurotoxicity: Systematic review and consensus expert opinion. Expert Rev Neurother 2022;22:65-76. [PMID: 34894974 DOI: 10.1080/14737175.2022.2018300] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Behrouzi A, Fehrenbacher JC. Chemotherapy-Induced Peripheral Neuropathy. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00109-2] [Reference Citation Analysis]
14 Tran H, Johnson GVW. Chemotherapeutics That Impair Microtubule Function: Axonopathy and Peripheral Neuropathies. Pathogenesis of Neuropathic Pain 2022. [DOI: 10.1007/978-3-030-91455-4_7] [Reference Citation Analysis]
15 Zhang S. Chemotherapy-induced peripheral neuropathy and rehabilitation: A review. Semin Oncol 2021;48:193-207. [PMID: 34607709 DOI: 10.1053/j.seminoncol.2021.09.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
16 Ogle T, Alexander K, Yates P, Paul SM, Kober KM, Conley YP, Schumacher M, Levine JD, Miaskowski C. Occurrence and perceived effectiveness of activities used to decrease chemotherapy-induced peripheral neuropathy symptoms in the feet. Eur J Oncol Nurs 2021;54:102025. [PMID: 34500317 DOI: 10.1016/j.ejon.2021.102025] [Reference Citation Analysis]
17 Waibel S, Wehrle A, Müller J, Bertz H, Maurer C. Type of exercise may influence postural adaptations in chemotherapy-induced peripheral neuropathy. Ann Clin Transl Neurol 2021;8:1680-94. [PMID: 34278743 DOI: 10.1002/acn3.51426] [Reference Citation Analysis]
18 Amiri A, Chovanec M, Oliva V, Sedliak M, Mego M, Ukropec J, Ukropcová B. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise. Andrology 2021. [PMID: 34245663 DOI: 10.1111/andr.13078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Kang GE, Murphy TK, Kunik ME, Badr HJ, Workeneh BT, Yellapragada SV, Sada YH, Najafi B. The detrimental association between fear of falling and motor performance in older cancer patients with chemotherapy-induced peripheral neuropathy. Gait Posture 2021;88:161-6. [PMID: 34091147 DOI: 10.1016/j.gaitpost.2021.05.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Zheng JY, Mixon AC, McLarney MD. Safety, Precautions, and Modalities in Cancer Rehabilitation: an Updated Review. Curr Phys Med Rehabil Rep 2021;:1-12. [PMID: 34178432 DOI: 10.1007/s40141-021-00312-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Lees JG, Abdulla M, Barkl-Luke ME, Livni L, Keating BA, Hayes J, Fiore NT, Park SB, Moalem-Taylor G, Goldstein D. Effect of exercise on neuromuscular toxicity in oxaliplatin-treated mice. Muscle Nerve 2021;64:225-34. [PMID: 34036599 DOI: 10.1002/mus.27329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Tanay MAL, Armes J, Moss-morris R, Rafferty AM, Robert G. A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms. J Cancer Surviv. [DOI: 10.1007/s11764-021-00997-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
23 Timmins HC, Li T, Goldstein D, Trinh T, Mizrahi D, Harrison M, Horvath LG, Friedlander M, Kiernan MC, Park SB. The impact of obesity on neuropathy outcomes for paclitaxel- and oxaliplatin-treated cancer survivors. J Cancer Surviv. [DOI: 10.1007/s11764-021-01012-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
24 Wang AB, Housley SN, Flores AM, Kircher SM, Perreault EJ, Cope TC. A review of movement disorders in chemotherapy-induced neurotoxicity. J Neuroeng Rehabil 2021;18:16. [PMID: 33494755 DOI: 10.1186/s12984-021-00818-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
25 Timmins HC, Mizrahi D, Li T, Kiernan MC, Goldstein D, Park SB. Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review. J Cancer Surviv 2021. [PMID: 33438175 DOI: 10.1007/s11764-021-00988-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
26 Kleckner IR, Park SB, Streckmann F, Wiskemann J, Hardy S, Mohile N. Systematic Review of Exercise for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy. Diagnosis, Management and Emerging Strategies for Chemotherapy-Induced Neuropathy 2021. [DOI: 10.1007/978-3-030-78663-2_8] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Toale KM, Johnson TN, Ma MQ, Vu NH. Chemotherapy Toxicities. Oncologic Emergency Medicine 2021. [DOI: 10.1007/978-3-030-67123-5_48] [Reference Citation Analysis]
28 Kondylakis H, Axenie C, Kiran Bastola D, Katehakis DG, Kouroubali A, Kurz D, Larburu N, Macía I, Maguire R, Maramis C, Marias K, Morrow P, Muro N, Núñez-Benjumea FJ, Rampun A, Rivera-Romero O, Scotney B, Signorelli G, Wang H, Tsiknakis M, Zwiggelaar R. Status and Recommendations of Technological and Data-Driven Innovations in Cancer Care: Focus Group Study. J Med Internet Res 2020;22:e22034. [PMID: 33320099 DOI: 10.2196/22034] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
29 Chen S, Huang H, Huang W, Lin Y, Chu T, Beaton RD, Jane S. Non-randomized preliminary study of an education and elastic-band resistance exercise program on severity of neuropathy, physical function, muscle strength and endurance & quality of life in colorectal cancer patients experiencing oxaliplatin-induced peripheral neuropathy. European Journal of Oncology Nursing 2020;49:101834. [DOI: 10.1016/j.ejon.2020.101834] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Corrà MF, Warmerdam E, Vila-Chã N, Maetzler W, Maia L. Wearable Health Technology to Quantify the Functional Impact of Peripheral Neuropathy on Mobility in Parkinson's Disease: A Systematic Review. Sensors (Basel) 2020;20:E6627. [PMID: 33228056 DOI: 10.3390/s20226627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Jesson T, Runge N, Schmid AB. Physiotherapy for people with painful peripheral neuropathies: a narrative review of its efficacy and safety. Pain Rep 2020;5:e834. [PMID: 33490836 DOI: 10.1097/PR9.0000000000000834] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
32 Varedi M, Lu L, Phillips NS, Partin RE, Brinkman TM, Armstrong GT, Chase E, Khan RB, Powell D, McKenna RF, Robison LL, Hudson MM, Ness KK. Balance impairment in survivors of pediatric brain cancers: risk factors and associated physical limitations. J Cancer Surviv 2021;15:311-24. [PMID: 32895869 DOI: 10.1007/s11764-020-00932-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
33 Li T, Timmins HC, Lazarus HM, Park SB. Peripheral neuropathy in hematologic malignancies – Past, present and future. Blood Reviews 2020;43:100653. [DOI: 10.1016/j.blre.2020.100653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
34 Axenie C, Kurz D. Role of Kinematics Assessment and Multimodal Sensorimotor Training for Motion Deficits in Breast Cancer Chemotherapy-Induced Polyneuropathy: A Perspective on Virtual Reality Avatars. Front Oncol 2020;10:1419. [PMID: 32903366 DOI: 10.3389/fonc.2020.01419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Kondylakis H, Axenie C, (Kiran) Bastola D, Katehakis DG, Kouroubali A, Kurz D, Larburu N, Macía I, Maguire R, Maramis C, Marias K, Morrow P, Muro N, Núñez-benjumea FJ, Rampun A, Rivera-romero O, Scotney B, Signorelli G, Wang H, Tsiknakis M, Zwiggelaar R. Status and Recommendations of Technological and Data-Driven Innovations in Cancer Care: Focus Group Study (Preprint).. [DOI: 10.2196/preprints.22034] [Reference Citation Analysis]
36 Makiura D, Saito T, Inoue J, Doi H, Yakushijin K, Sakai Y. Effect of 16-week Outpatient Rehabilitation on Symptom Burden and Physical Function in a Patient with Plasmacytoma Diagnosed with Chemotherapyinduced Peripheral Neuropathy:A Case Report. Jpn J Rehabil Med 2020;57:565-570. [DOI: 10.2490/jjrmc.19016] [Reference Citation Analysis]
37 Ogle T, Alexander K, Miaskowski C, Yates P. Systematic review of the effectiveness of self-initiated interventions to decrease pain and sensory disturbances associated with peripheral neuropathy. J Cancer Surviv 2020;14:444-63. [PMID: 32080785 DOI: 10.1007/s11764-020-00861-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
38 Knoerl R, Gilchrist L, Kanzawa-lee GA, Donohoe C, Bridges C, Lavoie Smith EM. Proactive Rehabilitation for Chemotherapy-Induced Peripheral Neuropathy. Seminars in Oncology Nursing 2020;36:150983. [DOI: 10.1016/j.soncn.2019.150983] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
39 Alberti P, Cavaletti G, Cornblath DR. Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity. Current Opinion in Neurology 2019;32:676-83. [DOI: 10.1097/wco.0000000000000724] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
40 Andersen Hammond E, Pitz M, Shay B. Neuropathic Pain in Taxane-Induced Peripheral Neuropathy: Evidence for Exercise in Treatment. Neurorehabil Neural Repair. 2019;33:792-799. [PMID: 31342880 DOI: 10.1177/1545968319860486] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
41 Alvarado I, Wisotzky E, Cheville AL. Differences in Perceived Risk at Which Clinician and Patient Stakeholders Initiate Activities to Prevent Late Effects Among Breast Cancer Survivors. Arch Rehabil Res Clin Transl 2019;1:100006. [PMID: 33543046 DOI: 10.1016/j.arrct.2019.100006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 McCrary JM, Goldstein D, Wyld D, Henderson R, Lewis CR, Park SB. Mobility in survivors with chemotherapy-induced peripheral neuropathy and utility of the 6-min walk test. J Cancer Surviv 2019;13:495-502. [PMID: 31172429 DOI: 10.1007/s11764-019-00769-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]